牛牛AI助理已提取核心訊息
Bruce Gerald W, the Chief Executive Officer of Virpax Pharmaceuticals, Inc. (VRPX), was involved in a transaction on January 29, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As the CEO of the company, Bruce Gerald W's transactions are closely watched by investors for insights into executive confidence in the company's performance and prospects.
Bruce Gerald W, the Chief Executive Officer of Virpax Pharmaceuticals, Inc. (VRPX), was involved in a transaction on January 29, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As the CEO of the company, Bruce Gerald W's transactions are closely watched by investors for insights into executive confidence in the company's performance and prospects.
Virpax Pharmicals, Inc.（VRPX）首席執行官布魯斯·傑拉爾德·W於2024年1月29日參與了一筆交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。作爲公司的首席執行官，Bruce Gerald W的交易受到投資者的密切關注，以深入了解高管對公司業績和前景的信心。
Virpax Pharmicals, Inc.（VRPX）首席執行官布魯斯·傑拉爾德·W於2024年1月29日參與了一筆交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。作爲公司的首席執行官，Bruce Gerald W的交易受到投資者的密切關注，以深入了解高管對公司業績和前景的信心。
有用
沒用